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1. Introduction 
Paraneoplastic limbic encephalitis (PLE) is a rare neurological syndrome characterized by 
short-term memory impairment, seizures and various psychiatric disturbances. It is often 
associated with small-cell lung cancer, germ-cell tumors of the testis and breast cancer, but 
rarely with ovarian teratomas (Gultekin et al., 2000).  Several cases of PLE with ovarian 
teratomas had been reported in Japan (Okamura, Oomori, and Uchitomi, 1997; Nokura et 
al., 1997), but the autoantigens in this disease remained unknown.  In 2005, Dalmau et al. 
reported an antibody to the membranes of neurons of the hippocampus (antigens 
colocalized with exchange factor for ADP-ribosylation factor 6 A (EFA6A)) in association 
with PLE and ovarian teratomas (Ances et al., 2005; Vitaliani et al., 2005).  
We sent samples from a patient suffering from limbic encephalitis with an ovarian teratoma 
to Prof. Dalmau’s Laboratory in November 2005.  They identified antibodies to the antigens 
colocalized with EFA6A in our patient’s samples (Figure 1) (Shimazaki et al., 2007), and in 
another Japanese one (Koide et al., 2007). 
Their further analysis of the antibodies disclosed that were ones against NR1/NR2 
heteromers of N-methyl-D-aspartate (NMDA) receptors.  They diagnosed and reported 
twelve women (including our case) as having ‘paraneoplastic anti-NMDA receptor 
encephalitis associated with an ovarian teratoma’, the cases developing prominent 
psychiatric symptoms, amnesia, seizures, frequent dyskinesias, autonomic dysfunction, and 
a decreased level of consciousness often requiring ventilatory support (Dalmau et al., 2007).  
After this publication, several reports about anti-NMDA receptor encephalitis have 
appeared in Japan (Iizuka et al., 2008; Seki et al., 2008; Kataoka, Dalmau, and Ueno, 2008; 
Ishiura et al., 2008; Shindo et al., 2009).  Analysis of a worldwide one hundred anti-NMDA 
receptor encephalitis case series revealed that about 60% of them had associated tumors 
such as ovarian teratomas (Dalmau et al., 2008). 
Meanwhile, Kamei et al. proposed ‘acute juvenile female non-herpetic encephalitis 
(AJFNHE)’ (Kamei et al., 2009).  The clinical symptoms and course of AJFNHE are similar to 
those of anti-NMDA receptor encephalitis.  These two diseases are considered to be the 
same clinical entity, anti-NMDA receptor antibodies being detected in samples from some 
AJFNHE cases.   
We herein describe five young Japanese cases who had fever, psychiatric symptoms and 
orofacial dyskinesias, and whose sera and cerebrospinal fluids (CSF) contained antibodies 
against NMDA receptors.  
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Fig. 1. Detection of anti-NMDA receptor antibodies in cerebrospinal fluid of case 3. 
Antibodies for the NR1/NR2 heteromers of NMDA receptors caused intense 
immunolabelling of cultured rat neuronal cell membranes and processes. 
2. Characteristic clinical features of anti-NMDA receptor encephalitis 
The clinical symptoms of 100 cases of anti-NMDA receptor encephalitis have been reported 
in detail (Dalmau et al., 2008).  According to this report, the median age of patients was 23 
years (range, 5-76 years), and 91 out of the 100 cases were women. 
In our cases (Table 1), the time of disease onset ranged from 17 to 30 of age.  Four cases were 
female and one was male.  Headache, fever and flu-like symptoms preceded other 
encephalitis features in our cases and about 90% of the above 100 cases (Dalmau et al., 2008).  
To our knowledge, antecedent infection has not been described for this disease, but case 5 
had suffered from influenza B infection before his psychiatric symptoms emerged. 
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2.1 Psychiatric symptoms 
Seventy-seven of 100 anti-NMDA receptor encephalitis cases developed marked 
schizophrenia-like psychiatric symptoms at onset (Dalmau et al., 2008), and they tended to 
have visited a psychiatric clinic initially.  The psychiatric symptoms were as follows: 
anxiety, agitation, bizarre behavior, delirium, visual and auditory hallucination, and short-
term memory disturbance.  Catatonia-like symptoms have been reported (Lee, Glick, and 
Dinwiddie, 2006; Iizuka et al., 2008; Kleinig et al., 2008; Schimmel et al., 2009).  Emotional 
incontinence and disorientation were observed in our series. 
Notably, our case 5 showed prominent psychiatric symptoms such as abnormal behavior, 
hallucination and agitation with mild orofacial dyskinesia, although convulsions, 
abnormal eye movements, autonomic instability, hypoventilation and CSF pleocytosis 
were not observed.  Modified electroconvulsive therapy was effective for his psychiatric 
symptoms that were uncontrolled with medications due to their side effects (Ando et al., 
2011). 
Recently, anti-NMDA receptor antibodies were detected in a small percentage of patients 
with a first episode of psychosis (Zandi et al., 2011), and in cases with a pure 
neuropsychiatric disorder (De Nayer, Myant, and Sindic, 2009).  A good response to 
electroconvulsive therapy has been reported for anti-NMDA receptor encephalitis 
(Braakman et al., 2010).  
2.2 Involuntary movements 
Involuntary movements are one of the most characteristic symptoms of anti-NMDA 
receptor encephalitis.  They were seen in 85 of 100 anti-NMDA receptor encephalitis cases.  
The most frequent types were orofacial dyskinesia including grimacing, masticatory-like 
movements, and forceful jaw opening and closing (Dalmau et al., 2008).  Other types of 
involuntary movement were also observed, as follows: choreiform movement, dystonic 
posture and myoclonus.  It is suggested that interruption of forebrain corticostriatal inputs 
by anti-NMDA receptor antibodies removes tonic inhibition of brainstem pattern generators 
releasing primitive patterns of bulbar and limb movement (Kleinig et al., 2008). 
In our cases, we observed blinking and grimacing, to and fro dyskinesia of the tongue, 
tremorous movements of the extremities, and increasing paroxysmal muscle tonus 
throughout the whole body.  In patients 1 and 3, the orofacial dyskinesia was too severe to 
break their teeth, whereas that in case 5 was mild and of short duration.  
2.3 Oculomotor symptoms 
Oculogyric crisis has been reported as the most frequent oculomotor finding in anti-NMDA 
receptor encephalitis (Ko, Dalmau, and Galetta, 2008).  Moreover, nystagmus and deviation 
of the ocular position have been observed in some cases (Dalmau et al., 2008). 
In our cases, we observed oculogyric crisis in case 1, disconjugation in case 2, and skew 
deviation and inverse ocular bobbing in case 3 (Shimazaki et al., 2008) (Fig. 2)(Table 1).  
Inverse ocular bobbing, referred to as ocular dipping, consists of a slow, spontaneous 
downward eye movement with fast return to midposition. It may be observed in anoxic 
coma (Ropper, 1981) or following prolonged status epileptics (Mehler, 1988), and is thought 
to be a marker of diffuse brain damage (Stark, Masucci, and Kurtzke, 1984).  This case had 
not only signs of brainstem involvement such as skew deviation and hypoventilation, but 
also of diffuse encephalopathy, causing the inverse ocular bobbing.   
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Patient No. 1 2 3  4 5 
Onset age，Gender 22, F 19, F 30, F 16, F 18, M 
Initial symptoms 
(Prodromes) 
emotional 
incontinence, 
restlessness, fever, 
headache 
disorientation,  
emotional 
incontinence, 
fever, headache, 
nausea 
disorientation, 
fever, headache, 
nausea 
abnormal 
behavior, 
convulsions, 
fever, headache 
fever (influenza 
B), abnormal 
behavior, 
hallucination, 
agitation 
Seizures clonic clonic tonic tonic - 
Orofacial & limb 
dyskinesia 
++ +++ ++ + +- 
Duration of dyskinesia 9 weeks > 5 weeks 2 weeks 4 weeks 2 days 
Eye position, movement oculogyric crisis disconjugation 
skew deviation, 
inverse ocular 
bobbing  
horizontal 
nystagmus like 
- 
Autonomic instability ++ ++ ++ + - 
Hypersalivation ++ +++ +++ +- - 
Ventilatory assistance 12 weeks > 6 weeks 6 weeks - - 
Hospital stay (months) 5.5 2 3.5 2 4 
CSF cells (/µl) 104 242 40 10 1 
CSF protein (mg/dl) 26 55 67 32 20 
CSF glucose (mg/dl) 70 48 67 72 70 
MRI (FLAIR) 
high intensity 
unremarkable unremarkable 
medial temporal, 
hippocampus 
right pontine 
base, right 
cerebellum 
unremarkable 
EEG !  !  " -!  " -!  normal 
Ovarian teratoma 
mature cystic 
(dermoid cyst) 
(not detected) 
immature,  
rapid enlargement 
(not detected) (not detected) 
Tumor markers 
(CA19-9, CA125) 
CA19-9 <1 
CA125 18  
(not examined) 
CA19-9 138 
CA125 65 
CA19-9 52 
CA125 19 
CA19-9 2 
 
Time to tumor diagnosis 47 months - 0.5 months - - 
NR1 antibody titer in 
CSF (rfu, normal < 5000) 
444556 2197200 31360 
NR1/NR2 
antibody + 
NR1/NR2 
antibody + 
Therapy 
CS, tumor 
resection 
CS, PP, IVIg 
CS, PP, IVIg, 
tumor resection 
IVIg, CS 
electroconvulsive 
therapy 
Outcome  
recovery (1 year 8 
months) 
w/epilepsy 
death (2 months) 
full recovery  
(1 year) 
full recovery  
(11 months) 
full recovery 
(1 year) 
 
Table 1. Clinical and laboratory findings in five cases of anti-NMDA receptor encephalitis. 
rfu: relative fluorescence units. 
δ δ θ-δ θ-δ
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Fig. 2. The position of the eyes in case 3 showed skew deviation when the inverse ocular 
bobbing resolved. 
2.4 Autonomic symptoms 
Anti-NMDA receptor encephalitis is complicated by autonomic instability, which is 
indicated by an unstable blood pressure level or pulse rate, hypersalivation, central 
hypoventilation, etc. 
We found excess salivary excretion of up to 1400ml/day in all cases except for patients 4 
and 5.  Case 3 suffered from sudden hypotension and bradycardia.  Three of the five cases 
were intubated and required mechanical ventilatory support due to the central 
hypoventilation, the other two cases not needing assisted ventilation.  
2.5 Ovarian teratomas 
Fifty-eight of 98 anti-NMDA receptor encephalitis patients had a neoplasm, the most 
frequent one being an ovarian teratoma (Dalmau et al., 2008).  Analysis of 400 patients 
confirmed that the younger the patient, the less likely that a tumor will be detected (Dalmau 
et al., 2011), and that in female patients older than 18 years, the frequency of an underlying 
teratoma is much the same as they previously reported (Dalmau et al., 2008). 
Of our cases, two (22 and 30 years old) had ovarian teratomas, the other three (16, 18 and 19 
years old) had no associated tumor.  The mature teratoma of an ovary in case 1 was not 
discovered in hospital with encephalitis symptoms, but was diagnosed four years after 
onset (Figure 3A-a, b).  The immature teratoma of an ovary in case 3 was detected at two 
weeks after onset (Figure 3B-a).  Pelvic MRI showed her enlarged teratoma, double in 
diameter, at two months after onset (Figure 3B-b) (Shimazaki et al., 2007).  Both teratomas 
were resected, but the tumors in the other three cases were not identified until now.  
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2.6 Brain MRI findings 
Brain MRI showed abnormal findings in 55 of 100 cases with anti-NMDA receptor 
encephalitis (Dalmau et al., 2008).  
Of our cases, cases 1, 2 and 5 exhibited no remarkable findings on the brain MRI.  FLAIR 
images of case 3 disclosed areas of high intensity in the bilateral medial temporal and 
hippocampal areas (Figure 4A-a), which disappeared after two months (Figure 4A-
b)(Shimazaki et al., 2007).  FLAIR images of case 4 showed areas of high intensity in the 
right ventral pons (Figure 4B-a) and the right cerebellum (Figure 4B-b).   
 
 
A. Pelvic T2-weighted MRI (a: axial, b: sagittal image) in case 1 at four years after onset.  It 
revealed a right ovarian teratoma with a diameter of 5 cm. It was resected and the 
pathological diagnosis was a mature teratoma (dermoid cyst). 
B. Pelvic enhanced CT in case 3.  CT at two weeks after onset (a) revealed a 5 cm tumor in 
the right ovary, which was considered to be a benign cyst unrelated to the neurological 
disorder. At two months after onset, the patient developed progressive constipation and a 
bulging appearance of the lower abdomen. Follow-up abdominal computed tomography (b) 
and MRI showed an enlarged ovarian tumor, with a transverse diameter of 10 cm. Resection 
of the tumor revealed an immature teratoma that contained hair follicles, cartilage tissue, 
glandular structures and cerebral cortex-like tissue with normal appearing neurons. No 
inflammatory infiltrates were evident in the tumor. 
Fig. 3. Ovarian teratomas in cases 1 and 3. 
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A. Brain MRI in case 3. Axial plane and Gadolinium-enhanced T1-weighted MRI were 
unremarkable, but MRI   fluid-attenuated inversion recovery images of the brain showed 
areas of hyperintensity in the medial temporal lobes and hippocampus on admission (A-a). 
These abnormalities had resolved by two months after admission (A-b). 
B. Brain MRI in case 4. Axial plane and Gadolinium-enhanced T1-weighted MRI were 
unremarkable, but T2-weighted and FLAIR images showed areas of slightly high intensity 
in the right ventral pons (a) and cerebellum (b). 
Fig. 4. Brain MRI (FLAIR) findings in two patients (cases 3 and 4). 
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2.7 Electroencephalography (EEG) 
Generalized or frontotemporal slow waves were observed in 71 of 100 cases with anti-
NMDA receptor encephalitis.  Epileptic discharges were only recorded in 22 of the 100 cases 
(Dalmau et al., 2008).   The EEG records for all our cases except for case 5 mainly showed 
slow waves in the theta to delta ranges.   
2.8 Cerebrospinal fluid findings 
Cerebrospinal fluid (CSF) examination disclosed abnormal findings in 95 of 100 cases 
(Dalmau et al., 2008).  Lymphocytic pleocytosis was found in 91 cases, and increased protein 
concentrations in 32 of the 100 cases. 
In our cases, mild to moderate pleocytosis was found in all patients except for patient 5.  
CSF protein elevation was only observed in two cases (patients 2 and 3).   
3. Treatment and prognosis 
Several effective treatments have been reported for anti-NMDA receptor encephalitis other 
than the administration of steroids, immunoglobulin, and plasmapheresis.  Ovarian tumor 
removal in the acute phase (Sansing et al., 2007; Seki et al., 2008), chemotherapy for the 
tumors (Eker et al., 2008), cyclophosphamide (Sansing et al., 2007; Wilder-Smith and Ng, 
2008), and rituximab (Ishiura et al., 2008) were also effective treatments for a small number 
of cases. 
In our cases (Table 1), corticosteroids were administered to four cases, and high-dose 
intravenous gammaglobulin to three cases.  We performed plasmapheresis for two cases.  
Two women underwent resection of ovarian teratomas.  Modified electroconvulsive therapy 
was found to be dramatically effective for the psychiatric symptoms in case 5.   
The severity of anti-NMDA receptor encephalitis is incompletely correlated with the titer of 
anti-NMDA receptor antibodies in the acute phase. (Prof. Dalmau, written communication 
Jul 2008).  
In our cases, we did know the titers in three (Table 1).  Case 3 exhibited the lowest titer with 
a full recovery, whereas case 2 exhibited the highest titer with severe involuntary 
movements and poor prognosis.   
The prognosis of anti-NMDA receptor encephalitis had relatively good compared to that of 
herpes simplex encephalitis.  Of 100 cases, 47 exhibited full recovery, 28 mild stable deficits, 
18 severe deficits, and seven died as a result of the neurological disorder (Dalmau et al., 
2008).   Our three cases exhibited a complete recovery, one had mild sequelae with epilepsy, 
and one died.   
4. Conclusions 
We have discussed five cases of anti-NMDA receptor encephalitis compared to the other 
numerous reported cases.  From the clinical aspect, our cases and the reported ones had 
some symptoms in common, for example, preceding psychiatric symptoms, and 
characteristic orofacial dyskinesia. 
Meanwhile, the clinical manifestations in our cases included a peculiar ocular symptom 
(ocular dipping) in case 3 and an atypical clinical presentation (predominant schizophrenic 
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psychiatric symptoms) in case 5.  In particular, case 5 was initially misdiagnosed as having 
schizophrenia by a psychiatrist because of no findings of encephalitis (no CSF pleocytosis, 
normal brain MRI and EEG).  Ovarian teratomas were found in two patients, one became 
rapidly enlarged in hospital, and the other was found at four years after onset.  Therefore, 
we should carefully follow up patients even if the tumors are not identified during 
hospitalization.  In our experience, anti-NMDA receptor encephalitis exhibits severe 
symptoms such as convulsions and hypoventilation in the acute phase, but this disease 
could be curable.  Characteristic symptoms and antibody measurement can be useful for 
prompt diagnosis of this disease, and early immunosuppressive treatment and tumor 
resection are important as well as general care of critically ill patients. 
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